First U.S. Women Receive Breast Augmentation with FDA-Approved Motiva Implants
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.
Establishment Labs Holdings Inc, a global medical technology company specializing in women’s health, announces the first U.S. breast augmentations using Motiva Implants.
Below, Deepak Dugar, MD, a facial plastic surgeon specializing in closed scarless nose rhinoplasty, discusses how GLP-1 medications like Ozempic impact body composition. He highlights concerns about rapid weight loss causing sagging and volume loss in the buttocks, breasts, and face, posing challenges for both patients and physicians.
A study in Plastic and Reconstructive Surgery found that a machine learning algorithm effectively predicts the risk of persistent opioid use after hand surgery, potentially aiding in identifying high-risk patients and optimizing pain management strategies.
The U.S. FDA has granted additional 510(k) clearance for Morpheus8 for soft-tissue contraction, coinciding with the launch of the IgniteRF and OptimasMAX platforms.
In an era of escalating cyber threats, safeguarding patient data in plastic surgery practices is paramount, given the potential risks to trust and ethical integrity. Here are seven steps PSPs must take to enhance cybersecurity.